Skip to content

Performance Assessement for Paralympic Athletes

Evaluation of Performance in Paralympic Athletes: Performance Outcomes in Sports

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04748497
Acronym
PARAPERF
Enrollment
134
Registered
2021-02-10
Start date
2021-01-08
Completion date
2024-06-30
Last updated
2022-03-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Paralympic Athletes, Sportive Performance

Keywords

paralympic athletes, performance

Brief summary

The primary objective of the study: improvement of sportive performances by quantification and performances monitoring of paralympic athletes. The secondary objectives of the study: * quantification and performances monitoring of mechanical performances during the filed tests, the laboratory analysis and the sportive competitions; * quantification and performances monitoring of physiological performances during the filed tests, the laboratory analysis and the sportive competitions; * quantification and risk monitoring of discipline-relative musculo-squeletic troubles, caused by training or using of sportive equipment; * quantification and mechanical monitoring by the made-to-measure or usual sportive material.

Detailed description

The sportive performance results from a range of determinations such as: physiological, biomechanical, morphological, psychological, social and environmental factors. The interactions between athletes, equipment, training and environment influences the development of athletes' performance. In the context of the coming Paris 2024 Paralympic Games, the performance construction for the exploration, the quantification and the management of all factors is an commun objective between sportive team, medical team and researchers.

Interventions

OTHERStandardization of evaluation and follow-up

Standardization of evaluation and clinical and sportive follow-up of athletes. Made-to-measure technical supports will be tested regarding the Paralympic regulations.

Sponsors

Assistance Publique - Hôpitaux de Paris
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
14 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* High-lever paralympic athletes registered on the ministerial list or selected by Parasport Federation of France or Shooting Federation of France; * Aged \>= 14 years; * Informed consent signed by adult athlete or by holder of parental authority or guardian for minor athlete; * Covered by social security system.

Exclusion criteria

* Temporary or definitive contraindication to the practice of the affected sport activity; * Undergoing anti-coagulated treatments; * Cognitive disabilities conducting impossibility to participating to clinical trial, such as serious cognitive troubles, behaviors troubles, psychic troubles or upgraded curatorship needing; * Under guardianship or judicial decision; * Ongoing pregnancy.

Design outcomes

Primary

MeasureTime frameDescription
Dynamic sportive activitythrough study completion, an average of 1 yearDynamic sportive activity: Sprint Capacity Test will be used to have maximal speed.
Static sportive activitythrough study completion, an average of 1 yearStatic sportive activity: maximal speed of movement of pression center.

Secondary

MeasureTime frameDescription
Physiological indices of performance: maximal aerobic speed (MAS)Twice through study completion, an average of 42 monthsMaximal aerobic speed (MAS) will be measured by Repetition Per Minute on a Arm ergometer.
Physiological indices of performance: maximal aerobic powerTwice through study completion, an average of 42 monthsMaximal aerobic power will be measured by following Watts fluctuation during the incremental hand-biking test.
Fatigue assessmentTwice through study completion, an average of 42 monthsFatigue assessment will be measured by Fatigue Index (Power max ratio).
Blood lactate concentrationimmediately after the interventionBlood lactatemia level will be measured by lactometer.
VO2 peak oxygen uptakethrough study completion, an average of 1 yearVO2 peak oxygen uptake
Peak breath expiration volume assessmentthrough study completion, an average of 1 yearVE peak: peak breath expiration volume
Biomechanical indices of performance: isometric power measurementthrough study completion, an average of 1 yearIsometric power will be measured by MicroFet & handgrip of 26 measures, advice for healthcare professionals to measure handgrip strength forces to test and document grip deficits and to evaluate consistency of effort.
Musculo-squeletic troubles risks measurementthrough study completion, an average of 1 yearMusculo-squeletic troubles risks will be measured by medical following and clinical method of functional assessment of the shoulder (i.e. Constant scale).
Time and distance of deceleration of wheelchair during riding testthrough study completion, an average of 1 yearTime and distance of deceleration of wheelchair during riding test: measured by signal analysis of instrumented wheelchair (inertial control units).
Mechanical indices of wheelchair propulsion - applied forces on handrim during the propulsionthrough study completion, an average of 1 yearApplied forces on handrim during the propulsion: measured by force platform.
Acceleration profil during the propulsionthrough study completion, an average of 1 year
Speed profil during the propulsionthrough study completion, an average of 1 year
Peak cardiac frequencethrough study completion, an average of 1 yearCF: peak cardiac frequence
Biomechanical indices of performance: arms and shoulder's Strengththrough study completion, an average of 1 yearArms and shoulder's Strength will be measured by force platform.

Countries

France

Contacts

Primary ContactJean François Toussaint, MD, PhD
jean-francois.toussaint@aphp.fr+33 (0)1 42 34 82 10
Backup ContactFrançois Genêt, MD, PhD
francois.genet@aphp.fr+33 (0)1.47.10.70.68

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026